GlassScriptPhysician profile
Daniel R Frisch
NPI 1760590749
$77,458.40
in general payments reported to CMS, 2019-2025
31 companies · $9,262 in 2025
The $9,262 reported for 2025 was more than what 79% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $8,900 · 2021: $15K · 2022: $15K · 2023: $10K · 2024: $4,620 · 2025: $9,262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,652 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,675 · Travel and Lodging: $4,433 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,025 · Consulting Fee: $3,525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,652.32 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,675.00 |
| Travel and Lodging | $4,433.08 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,025.00 |
| Consulting Fee | $3,525.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $53,019.32 | 2019-2025 | Ensite, Gallant, Ensite Precision |
| Sanofi-Aventis U.S. LLC | $8,003.91 | 2021-2022 | |
| Atricure, INC. | $2,558.50 | 2021-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Boston Scientific Corporation | $2,237.46 | 2019-2025 | Watchman Flx, Farapulse, General - Therapies |
| Medtronic, INC. | $2,110.21 | 2021-2025 | Linq II, Micra, Aurora Ev-Icd Mri Surescan |
| Altathera Pharmaceuticals LLC | $2,030.74 | 2024 | Sotalol Hydrochloride |
| Medtronic Vascular, INC. | $1,141.05 | 2019-2020 | |
| Biosense Webster, INC. | $1,134.48 | 2022-2024 | Carto 3, Qdot Micro Catheter, Visitag Surpoint External Processing Unit |
| Medical Device Business Services, INC. | $1,062.04 | 2023 | Carto 3 |
| Edwards Lifesciences Corporation | $672.79 | 2019-2025 | |
| Eko Health, INC. | $598.00 | 2020 | |
| Amgen INC. | $529.04 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $509.73 | 2020-2025 | Camzyos, Eliquis |
| Zoll Respicardia, INC. | $384.86 | 2021-2022 | |
| Cardiva Medical, INC. | $299.14 | 2019-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Ensoetm |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $237.32 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $173.45 | 2019-2024 | Lifevest |
| Pfizer INC. | $158.71 | 2019-2025 | |
| Kestra Medical Technology Services, INC. | $111.57 | 2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $93.96 | 2023-2025 | |
| Impulse Dynamics (USA) INC. | $81.78 | 2023-2025 | Optimizer, Optimizer |
| Ethicon US, LLC | $81.31 | 2023-2025 | Ethicon, Stratafix |
| Baxter Healthcare | $41.68 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Becton, Dickinson and Company | $41.59 | 2022 | |
| Philips North America LLC | $33.80 | 2025 | Igt Devices Undivided |
| Cvrx, INC. | $22.27 | 2022 | |
| Kci USA, INC. | $21.08 | 2023 | Activ.A.C. |
| Medicomp INC | $19.09 | 2025 | Telepatch Cardiac Monitor |
| Portola Pharmaceuticals, LLC | $18.72 | 2020 | |
| Catheter Precision INC. | $17.18 | 2025 | |
| Astellas Pharma US INC | $13.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Frisch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.